IP Library Granted Patent US 10,030,015
Granted Patent B2
US 10,030,015 · App. 14/764,207 · Granted Jul 24, 2018

Amine compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity

Inventors: David M. Simpson (North Bethesda, MD); Dennis Bryan Zerby (Chambersburg, PA); Ming Lu (Bethesda, MD); Reid W. von Borstel (Potomac, MD); Rui Li (Darnestown, MD); Julian Reading (Frederick, MD); Stephen Wolpe (Boyds, MD); Nureddin Aman (Herndon, VA)
Assignee: Wellstat Therapeutics Corporation
C07D471/04A01N43/42A01N43/50A01N43/54A01N43/60A01N43/90A61K31/337A61K31/40A61K31/4164A61K31/4184A61K31/437A61K31/44A61K31/4425A61K31/472A61K31/475A61K31/4706A61K31/4709A61K31/4745A61K31/498A61K31/4965A61K31/505A61K31/517A61K31/555A61K31/704C07D209/12C07D213/73C07D213/74C07D215/38C07D215/40C07D215/42C07D215/44C07D215/46C07D233/60C07D235/08C07D239/42C07D239/94C07D241/20C07D241/44C07D401/12Y02A50/409Y02A50/411Y02P20/582
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,030,015
App. No.
14/764,207
Granted
Jul 24, 2018
Kind
B2
Abstract

Amine compounds having activity against inflammation, fungi, unicellular parasitic microorganisms, and cancer are described. The compounds contain a monocyclic, bicyclic, or tricyclic aromatic ring having one, two, or three ring nitrogen atoms.

Claims (54)

1. A compound represented by Formula IA1a or a pharmaceutically acceptable salt thereof

wherein n is 2, 3, 4, 5, 6, 7, or 8;

p is 1;

q is 0 or 1;

R 1 is hydrogen and R 2 is hydrogen;

R 4 is hydrogen; and

R 5 is selected from the group consisting of halo; alkoxy having from 1 to 10 carbon atoms unsubstituted or substituted by phenyl or phenoxy, provided that when substituted by phenoxy the alkoxy must have more than one carbon atom; phenyl; phenoxy; C(O)OR 6 ; C(O)NHR 6 ; or NHC(O)R 6 , wherein R 6 is alkyl having from 1 to 6 carbon atoms.

2. The compound or salt of claim 1 , wherein q is 0, and R 5 is alkoxy having from 1 to 6 carbon atoms unsubstituted or substituted by phenyl.

3. The compound or salt of claim 2 , wherein R 5 is in the ortho position.

4. The compound or salt of claim 3 , wherein the compound is selected from the group consisting of:

N-{2-[2-(Hexyloxy)phenoxy]ethyl}quinolin-4-amine,

N-{3-[2-(Hexyloxy)phenoxy]propyl}quinolin-4-amine,

N-{4-[2-(Hexyloxy)phenoxy]butyl}quinolin-4-amine,

N-[3-(2-Ethoxyphenoxy)propyl]quinolin-4-amine,

N-[3-(2-Methoxyphenoxy)propyl]quinolin-4-amine, and

N-{3-[2-(Benyloxy)phenoxy]propyl}quinolin-4-amine.

5. The compound or salt of claim 2 , wherein R 5 is in the meta position.

6. The compound or salt of claim 5 , wherein the compound is selected from the group consisting of:

N-[8-(3-Methoxyphenoxy)octyl]quinolin-4-amine,

N-{4-[3-(Hexyloxy)phenoxy]butyl}quinolin-4-amine,

N-{3-[3-(Hexyloxy)phenoxy]propyl}quinolin-4-amine, and

N-{2-[3-(Hexyloxy)phenoxy]ethyl}quinolin-4-amine.

7. The compound or salt of claim 2 , wherein R 5 is in the para position.

8. The compound or salt of claim 7 , wherein the compound is selected from the group consisting of:

N-[8-(4-Methoxyphenoxy)octyl]quinolin-4-amine,

N-[6-(4-Methoxyphenoxy)hexyl]quinolin-4-amine,

N-{2-[4-(Hexyloxy)phenoxy]ethyl}quinolin-4-amine,

N-{3-[4-(Hexyloxy)phenoxy]propyl}quinolin-4-amine, and

N-{4-[4-(Hexyloxy)phenoxy]butyl}quinolin-4-amine.

9. The compound or salt of claim 1 , wherein R 5 is fluoro.

10. The compound or salt of claim 9 , wherein the compound is selected from the group consisting of:

N-[8-(4-Fluorophenoxy)octyl]quinolin-4-amine,

N-[8-(3-Fluorophenoxy)octyl]quinolin-4-amine, and

N-[8-(2-Fluorophenoxy)octyl]quinolin-4-amine.

11. A compound represented by Formula IA1a or a pharmaceutically acceptable salt thereof

wherein n is 0;

p is 0;

q is 1;

R 1 is hydrogen and R 2 is hydrogen;

R 4 is hydrogen or halo; and

R 5 is alkoxy having from 1 to 10 carbon atoms, phenoxy, or alkoxy having from 1 to 10 carbon atoms substituted by phenyl.

12. The compound of claim 11 , wherein R 5 is alkoxy having from 1 to 10 carbon atoms.

13. The compound or salt of claim 12 , wherein the compound is selected from the group consisting of:

N-[4-(Hexyloxy)benzyl]quinolin-4-amine,

N-[2-(Hexyloxy)benzyl]quinolin-4-amine,

N-[3-Fluoro-4-(hexyloxy)benzyl]quinolin-4-amine,

N-[4-(Decyloxy)benzyl]quinolin-4-amine, and

N-[3-(Decyloxy)benzyl]quinolin-4-amine.

14. The compound of claim 11 , wherein R 5 is phenoxy, or alkoxy having from 1 to 10 carbon atoms substituted by phenyl.

15. The compound or salt of claim 14 , wherein the compound is selected from the group consisting of:

N-[3-(Benzyloxy)benzyl]quinolin-4-amine, and

N-(3-Phenethoxybenzyl)quinolin-4-amine.

16. N-[3-(Hexyloxy)benzyl]quinolin-4-amine or a pharmaceutically acceptable salt thereof.

17. N-(3-Phenoxybenzyl)quinolin-4-amine or a pharmaceutically acceptable salt thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 25, 2023
From: WELLSTAT THERAPEUTICS CORPORATION
To: PHARMA CINQ, LLC
Reel/Frame 065349/0494 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2023
From: WELLSTAT THERAPEUTICS CORPORATION
To: PHARMA CINQ, LLC
Reel/Frame 064806/0515 →
Continuity (2)
Provisional Application 61759512 · Feb 1, 2013
Related Publication 20150361077A1 · Dec 17, 2015
Cited By (1)
US 12,649,739